摘要
目的:评价重症肺心病患者应用低分子肝素钠治疗对临床指标和恢复时间的影响价值。方法:选取2017年9月~2018年9月期间某院收治的重症肺心病患者66例为研究对象,采用随机数字法分为参照组和低分子肝素钠组各33例。给予参照组吸氧、控制感染、控制心力衰竭、控制心律失常等常规方法进行治疗,低分子肝素钠组在常规方法治疗的基础上采用低分子肝素钠治疗,评价两组患者肺功能恢复时间、住院时间以及临床有效率。结果:低分子肝素钠组肺功能恢复时间(5.16±1.46)d、住院时间(10.56±1.14)d,均明显短于参照组(P<0.05);低分子肝素钠组临床有效率为93.94%,明显高于参照组(P<0.05)。结论:相比只采用常规方法治疗而言,重症肺心病患者应用低分子肝素钠治疗对临床指标和恢复时间的影响价值更加显著,安全性更高。
Objective:To evaluate the effect of LMWH sodium on clinical indicators and recovery time in patients with severe pulmonary heart disease.Methods:Sixty-six patients with severe pulmonary heart disease admitted to a hospital from September 2017 to September 2018 were selected and divided into the control group and the LMWH group by random number method.The control group(33 cases)was treated with oxygen inhalation,infection control,heart failure control,arrhythmia control and other conventional methods,while the LMWH group(33 cases)was treated with LMWH sodium on the basis of conventional methods.The recovery time of lung function,length of hospital stay and clinical effective rate in the 2 groups were evaluated.Results:The pulmonary function recovery time(5.16±1.46)d and hospital stay(10.56±1.14)d in the LMWH group were significantly shorter than those in the control group(P<0.05).Clinical effective rate of LMWH group was 93.94%,which was significantly higher than that of reference group(P<0.05).Conclusion:LMWH therapy has more significant and safer effect on clinical indicators and recovery time in patients with severe pulmonary heart disease than conventional therapy alone.
作者
徐爱敏
Xu Aimin(Fan County People's Hospital,Puyang City,Henan Province,Puyang 457500)
出处
《数理医药学杂志》
CAS
2021年第4期580-581,共2页
Journal of Mathematical Medicine
关键词
重症肺心病
低分子肝素钠
临床指标
恢复时间
影响价值
severe pulmonary heart disease
LMWH sodium
clinical indicators
recovery time
impact value
